...
首页> 外文期刊>American journal of therapeutics >A Case of Teicoplanin-Induced Pancytopenia Caused by Excessive Dosing
【24h】

A Case of Teicoplanin-Induced Pancytopenia Caused by Excessive Dosing

机译:过量投加引起替考拉宁诱导的全血细胞减少症一例

获取原文
获取原文并翻译 | 示例

摘要

Teicoplanin is reported to be as effective as vancomycin but with minimal side effects. We report a case of teicoplanin-induced pancytopenia, which has not been demonstrated previously. A 44-year-old man with tetraplegia was treated with a diagnosis of urinary tract infection and pneumonia, and a high-dose of teicoplanin (400 mg every 12 hours) was administered for 4 days inadvertently. Although the infection rapidly improved, the patient developed pancytopenia by the fourth day of teicoplanin therapy, which was improved after reducing the dose of teicoplanin (200 mg/d). Our patient represents a probable case of teicoplanin-induced pancytopenia with adverse drug reaction probability score of 6.
机译:据报道替考拉宁与万古霉素一样有效,但副作用最小。我们报告了一例替考拉宁诱导的全血细胞减少症,这之前没有得到证实。一名患有四肢瘫痪的44岁男性被诊断出患有尿路感染和肺炎,并意外服用了大剂量替考拉宁(每12小时400毫克),持续4天。尽管感染迅速好转,但患者在替考拉宁治疗的第四天出现了全血细胞减少症,减少替考拉宁剂量(200 mg / d)后病情得到改善。我们的患者代表替考拉宁诱导的全血细胞减少症的可能病例,药物不良反应概率评分为6。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号